Hematology TimesMRD predicts outcome of HSCT in ALL, study suggestsMarch 13, 2017Leukemia, Myelodysplasia, TransplantationPediatricsTransplantationALL
Hematology TimesStudy confirms increased adiposity in HSCT survivorsMarch 11, 2017Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersTransplantationAggressive Lymphomas
Hematology TimesGenetic variants linked to HSCT outcomes in ALLMarch 8, 2017Leukemia, Myelodysplasia, TransplantationTransplantationALL
Hematology TimesStudy advances precision opioid dosing for mucositisMarch 4, 2017PediatricsTransplantation
Hematology TimesSingle dose of ZA pre-transplant prevents bone lossMarch 1, 2017Leukemia, Myelodysplasia, TransplantationTransplantation
Hematology TimesFDA expands approved indication for lenalidomideFebruary 28, 2017Multiple MyelomaPharmacyTransplantation
Hematology TimesVZV vaccine reduces HZ incidence after HSCTFebruary 28, 2017Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersMultiple MyelomaTransplantation
Hematology TimesInpatient palliative care improves QOL for HSCT patientsFebruary 27, 2017Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersMultiple MyelomaTransplantation
Hematology TimesImmunotherapy receives fast track designationFebruary 22, 2017Lymphoma & Plasma Cell DisordersTransplantationHodgkin LymphomaNon-Hodgkin LymphomaAggressive Lymphomas
Hematology TimesGenetic profiling can guide HSCT in MDS, team saysFebruary 10, 2017AnemiaLeukemia, Myelodysplasia, TransplantationTransplantationMyelodysplastic Syndrome
